Cytological alterations in dermal dendrocytes in vitro: Evidence for transformation to a non-dendritic phenotype

British Journal of Dermatology

Volumn 143, Issue 1, 2000, Pages 84-90

  Monteiro, M R ^a   Murphy, E E ^a   Galaria, N A ^a   Whitaker Menezes, D ^a   Murphy, G F ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Dermal dendrocyte; Phenotype alteration; Skin organ culture

Indexed keywords

BLOOD CLOTTING FACTOR 13A; CD1 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; GLYCOPROTEIN IB; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ARTICLE; CELL SHAPE; CELL TRANSFORMATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOLOGY; DENDRITE; DENDROCYTE; DERMATOFIBROMA; FIBROHISTIOCYTOMA; HISTIOCYTE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MAST CELL DEGRANULATION; NEWBORN; ORGAN CULTURE; PHENOTYPE; PRIORITY JOURNAL; SKIN CELL;

ANTIGENS, CD34; DENDRITIC CELLS; FACTOR XIII; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; MAST CELLS; MICROSCOPY, ELECTRON; ORGAN CULTURE TECHNIQUES; PHENOTYPE; SKIN;

EID: 0033914390     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03595.x     Document Type: Article

References (32)

1. Headington JT. The dermal dendrocyte. In: Advances in Dermatology, Vol. l (Callen JP et al. eds). Chicago: Year Book Medical, 1986: 159.
2. Cerio R, Griffiths CE. Cooper KD et al Characterization of factor XIHa positive dermal dendritic cells in normal and inflamed skin. BrJDermatol 1989; 121: 421-31.
3. Monteiro MR. Shapiro SS, Takafuta T et al. Von Willebrand factor receptor GPIba is expressed by human dermal dendrocytes and is upregulated by mast cell degranulation. J Invest Dernmtol 1999: 113: 272-6.
4. Sontheimer RD, Matsubara T, Seelig LL. A macrophage phenotype for a constitutive, class II antigen-presenting human dermal perivascular dendritic cell. J Invest Dermatol 1989; 93: 154-9.
5. Nestle FO. Zheng XG, Thompson CB et al. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Imimmol 1993; 151:6535-45.
6. 6 Walsh LJ, Goerdt S, Pober JS et al. MS-1 sinusoidal endothelial antigen is expressed by factor XIIIa+, HLA-DR+ dermal perivascular dendritic cells, lab Invest 1991; 65: 732-41.
7. Sontheimer RD, Tharp MD. Immunological repertoire of the Dermal Microvascular Unit. In: Dermal Immune System (Nickoloff BJ. ed.). Boca Raton: CRC Press, 1993: 117-48.
8. 34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch Dermatol 1991: 127: 523-9.
9. Sueki H, Whitaker D. Buchsbaum M. Murphy GF. Novel interactions between DDs and mast cells in human skin. Implications for hemostasis and matrix repair. Lab Invest 1993; 69: 160-72.
10. Sueki H, Telegan B, Murphy GR Computer-assisted threedimensional reconstruction of human DDs. J Invest Dermatol 1995; 105: 704-8.
11. Walsh LJ, Trinchieri G, Waldorf HA et al. Human mast cells contain and release tumor necrosis factor a, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sei USA 1991: 88: 4220-4.
12. Morganroth GS, Chan LS, Weinstein GD et al Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa+ perivascular dendritic cells. J Invest Dermatol 1991; 96: 333-40.
13. Nickoloff BJ, Griffiths CE. Factor XHIa-expressing DDs in AIDSassociated cutaneous Kaposi's sarcomas. Science 1989; 243: 1736-7.
14. Gibran NS, Heimbach DM, Holbrook KA. Immunolocalization of FXIIIa+ dendritic cells in human burn wounds. J Surg Res 1995; 59: 378-86.
15. 34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma. Am J Dermatopathol 1997; 19: 147-53.
16. Misery L, Boucheron S, Claudy AL. Factor XHIa expression in juvenile xanthogranuloma. Acta Denn Venereologica 1994: 74: 43-4.
17. Meunier L, Gonzalez-Ramos A. Cooper KD. Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells. J Immunol 1993; 151: 4067-80.
18. Cooper KD, Fox P, Neises G, Katz SI. Flfects of ultraviolet radiation on human epidermal cell alloantigen presentation: initial depression of Langerhans cell-dependent function is followed by the appearance of T6- Dr+ cells that enhance epidermal alloantigen presentation. J Immunol 1985; 134: 129-37.
19. Baadsgaard 0, Lisby S, Avnstorp C et al Antigen-presenting activity of non-Langerhans epidermal cells in contact hypersensitivity reactions. Scand J Immunol 1990; 32: 217-24.
20. Nestle FO, Filgueira L, Nickoloff BJ, Burg G. Human dermal dendritic cells process and present soluble protein antigens. J Invest Dermatol 1998; 110: 762-6.
21. Altman DA, Fivenson DP, Lee MW. Minocycline hyperpigmentation: model for in situ phagocytic activity of factor Xllla positive dermal dendrocytes. J Cutan Pathol 1992; 19: 340-5.
22. Klein LM, Lavker RM, Matis \VL, Murphy GF. Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. Proc Natl Acad Sei USA 1996; 86: 8972-6.
23. Hosoi J. Murphy GF, Egan CL et al. Regulation of Langerhans cell function by nerves containing CGRP. Nature 1993; 363:159-63
24. Karnovsky MJ. A formaldehyde-glutaraldehye fixative of high osmolarity for use in electron microscopy. J Cell Biol 1965; 27: 137A.
25. Randolph GJ, Beaulieu S, Lebecque S et al Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 1998; 282: 480-3.
26. Aiba S, Tagami H. Phorbol 12-myristate 13-acetate can transform monocyte-derived dendritic cells to different cell types similar to those found in dermatofibroma. A possible in vitro model of the histogenesis of dermatofibroma. J Cutan Pathol 1998; 25: 65-71.
27. 34+ epithelioid and dendritic cells and factor XIIIa+ dendrophages. J Cutan Pathol 1996; 23: 551-7.
28. + cells in developing human skin. Anat Embryol 1996; 193: 35-41.
29. Messadi DV, Pober JS, Fiers W et al Induction of an activation antigen on post-capillary venular endothelium in human skin organ culture. J Immunol 1987; 139: 1557-62.
30. Kohno K, Hamanaka R, Abe T et al. Morphological change and destabilization of beta-actin mRNA by tumor necrosis factor in human microvascular endothelial cells. Exp Cell Res 1993; 208: 498-503.
31. Bacci S, NakamuraT, Streilein JW. Failed antigen presentation after UVB radiation correlates with modifications of Langerhans cell cytoskeleton. J Invest Dermatol 1996; 107: 838-43.
32. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990; 50: 537-44.